See how research connects peptides to biological targets, signaling pathways, and biological processes.
This tool shows, for each peptide, which biological target the available research points to, how directly that relationship is supported, and how it connects to broader signaling pathways and biological processes. It describes what research suggests about biological mechanisms -- not proven health or treatment outcomes, and not medical advice. See each peptide's full research profile for complete detail, citations, and safety information.
Mechanism research for MitoCore's current product catalog.
Showing 37 of 37 peptides
Evidence legend
Relationship support
Directly supported
Supported indirectly
Inferred from related evidence
Uncertain
Evidence context
Human research
Preclinical research
Human + preclinical research
Review / established literature
Related compound/program context
Evidence context uncertain
Understanding mechanism evidence
This tool describes research into biological targets, signaling pathways, and biological processes -- not proven health or treatment outcomes, and not medical advice. Relationship-support and evidence-context labels describe the type and directness of research available, not proof of safety or effectiveness. See each peptide's full research profile for complete detail, citations, and safety information.
Mechanism profiles
Modified GRF(1-29)
1 mechanism relationship · Supported indirectly · Related compound/program context
Biological processGrowth hormone secretion (analogue-supported, not exact-compound-demonstrated)
Relationship details
Modified GRF(1-29) → GHRH receptor — Supported indirectlyModified GRF(1-29) (CJC-1295 without DAC) shares the tetrasubstituted hGRF(1-29) analogue scaffold associated with GHRH-receptor activation; exact-compound primary receptor-binding data for this specific no-DAC form was not located.
Growth hormone secretion (analogue-supported, not exact-compound-demonstrated) — contributes to the pathway (structural link, no support rating)Sources: study-cjc-1295-with-dac-jette-2005-albumin-bioconjugate
A biological process is not the same as a proven health or treatment outcome.
Exact no-DAC-form primary GHRH-receptor binding/activation pharmacology was not located; support is analogue/scaffold-based (tetrasubstituted hGRF(1-29) chemistry shared with the DAC-conjugate development compound, plus earlier GRF-analogue receptor-binding structure-activity work). DAC-form pharmacokinetic properties and its long-acting albumin-binding profile are specific to the DAC conjugate and must NOT be transferred to this no-DAC record.
Sources
Central Citation Library reference: study-cjc-1295-with-dac-jette-2005-albumin-bioconjugate
Central Citation Library reference: cjc-no-dac-campbell-1991-grf-analogs-receptor-binding-pmid1656403
Key terms
Looking for research areas instead?
Peptide Explorer shows what areas a peptide is researched in. This tool shows how the underlying biology appears to work.
Educational use only. Not medical advice. MitoCore Biosciences does not diagnose, treat, cure, prevent, prescribe, sell peptides, recommend dosing, or provide instructions for human use.
